GLP 1 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Amylin Commands Weight Loss Attention as Industry Anticipates Novo's Phase III CagriSema Readout BioSpace Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Current Strategies in Managing Obesity STRIVE Obesity CagriTirz (Cagrilintide + Tirz) >99% Purity